Cognyte Software Ltd.
NASDAQ:CGNTSoftware - Infrastructure
-$0.14 today
- Market cap
- $577.47M
- Beta
- 1.64
- P/E (TTM)
- -224.1
- EPS (TTM)
- -$0.04
Volume 0.34M
Average 0.69M
CGNT Research & Development
Spending on developing new products, technologies, and improvements to existing offerings.
Cognyte Software Ltd.NASDAQ: CGNT
Research & Development · Q1 FY2027 · quarter ended Apr 2026
Research & development grows, but more slowly than its trailing trend
Q1 FY2027 research & development of $31.59M rose 8.5% year over year, behind the +12.2% change in trailing-twelve-month research & development. Sequentially, it fell 0.7% from the prior quarter. Over 3 fiscal years it compounded at -3.1% a year.
Context
- Research & development amounted to 31.9% of revenue in FY2026, up 1.0 pp from a year earlier.
- Research & development increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from +8.5% toward the trailing-twelve-month pace of +12.2%.
Sources:Income StatementText generated from reported figures; not investment advice.
Research & Development history
USD · from the income statement
- Latest · FY2026
- 127.51M USD
- Year-over-year change
- +17.8%
- 4-year CAGR
- -2.9%
| Period | Period end | Research & Development | YoY change |
|---|---|---|---|
| FY2026 | 2026-01-31 | 127.51M | +17.8% |
| FY2025 | 2025-01-31 | 108.27M | +0.9% |
| FY2024 | 2024-01-31 | 107.28M | -23.5% |
| FY2023 | 2023-01-31 | 140.32M | -2.1% |
| FY2022 | 2022-01-31 | 143.36M | — |
Research & Development vs competitors
How CGNT compares with its peers on the latest reported figures
- CGNT's LTM Apr 2026 research & development of $124.02M is the 9th highest of the 10 companies compared; the peer median is $223.97M.
- Its year-over-year change of +12.2% is the 5th highest of 10, against a peer median of +12.1%.
- Research & development amounts to 30.2% of revenue for CGNT, versus a peer median of 21.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Jul 2026 | $903.4M | +34.5% | +37.5% | 26.9% | |
| LTM Jun 2026 | $463.7M | +12.1% | +9.3% | 16.8% | |
| LTM Jul 2026 | $418M | +17.1% | +9.3% | 8.2% | |
| LTM Sep 2026 | $286.39M | +28.0% | +10.2% | 40.0% | |
| LTM Jun 2026 | $223.97M | +9.1% | +15.9% | 21.5% | |
| LTM Mar 2026 | $191.13M | +5.9% | +0.1% | 22.2% | |
| LTM Jun 2026 | $162.02M | +7.9% | -3.3% | 18.3% | |
| LTM Sep 2026 | $138.09M | +26.0% | +12.2% | 25.7% | |
| LTM Apr 2026 | $124.02M | +12.2% | -3.1% | 30.2% | |
| LTM Sep 2026 | $118.88M | +1.9% | +5.0% | 16.5% | |
| Peer median (excluding CGNT) | $223.97M | +12.1% | +9.3% | 21.5% | |
Competitors are the stored peer set for CGNT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2022 Jan 2022 | FY2023 Jan 2023 | FY2024 Jan 2024 | FY2025 Jan 2025 | FY2026 Jan 2026 |
|---|---|---|---|---|---|
| Revenue | 474.04M | 312.06M | 313.4M | 350.63M | 400.04M |
| Cost of Revenue | 132.4M | 119.94M | 98M | 103.71M | 110.75M |
| Gross Profit | 341.64M | 192.13M | 215.4M | 246.92M | 289.3M |
| Gross Margin | 72.1% | 61.6% | 68.7% | 70.4% | 72.3% |
| Research & Development | 143.36M | 140.32M | 107.28M | 108.27M | 127.51M |
| Selling, General & Admin | 185.87M | 154.35M | 125.78M | 143.52M | 158.43M |
| Operating Expenses | 330.68M | 295.45M | 233.46M | 252.05M | 285.94M |
| Depreciation & Amortization | 21.28M | 18.05M | 13.82M | 13.65M | 11.98M |
| EBITDA | 29.74M | (77.35M) | 573K | 9.38M | 14.09M |
| EBITDA Margin | 6.3% | -24.8% | 0.2% | 2.7% | 3.5% |
| Operating Income | 10.96M | (103.32M) | (18.05M) | (5.13M) | 2.12M |
| Operating Margin | 2.3% | -33.1% | -5.8% | -1.5% | 0.5% |
| Interest Income | 177K | 774K | 1.9M | 2.47M | 2.03M |
| Interest Expense | 196K | 1.6M | 16K | 100K | 194K |
| Other Income / Expenses | (2.7M) | 6.33M | 4.8M | 756K | 9.23M |
| Income Before Tax | 8.26M | (97M) | (13.26M) | (4.37M) | 11.34M |
| Pre-Tax Margin | 1.7% | -31.1% | -4.2% | -1.2% | 2.8% |
| Income Tax Expense | 18.52M | 12.96M | (1.61M) | 2.86M | 6.73M |
| Net Income | (14.89M) | (114.13M) | (15.57M) | (12.05M) | (638K) |
| Net Margin | -3.1% | -36.6% | -5.0% | -3.4% | -0.2% |
| EPS (Basic) | (0.22) | (1.68) | (0.22) | (0.17) | (0.01) |
| EPS (Diluted) | (0.22) | (1.68) | (0.22) | (0.17) | (0.01) |
| Weighted Avg Shares | 66.57M | 67.92M | 70.08M | 71.8M | 72.91M |
| Weighted Avg Shares (Diluted) | 66.57M | 67.92M | 70.08M | 71.8M | 72.91M |
Cognyte Software Ltd.
NASDAQ:CGNT
Intrinsic Alpha fair value
Locked
Current Price
$7.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.